Brief: Altamira Therapeutics Provides Update On Clinical Trials With Bentrio

Altamira Therapeutics

24/01/2023 13:29

Jan 24 (Reuters) - Altamira Therapeutics Ltd  CYTO.O :
    * ALTAMIRA THERAPEUTICS PROVIDES UPDATE ON CLINICAL TRIALS
WITH
BENTRIO
    * ALTAMIRA THERAPEUTICS LTD - NASAR MAIN TRIAL PHASE
COMPLETED;
FULL READ-OUT EXPECTED IN Q2 2023
    * ALTAMIRA THERAPEUTICS: DATA FROM TRIAL IN ACUTE COVID SHOW
TREND
FOR MORE PRONOUNCED REDUCTION IN NASAL VIRAL LOAD, SYMPTOMS, BUT
MAIN GOAL NOT MET
    * ALTAMIRA-ANALYSIS OF AUSTRALIAN NASAR TRIAL IN SEASONAL
ALLERGIC
RHINITIS SHOWS STATISTICALLY SIGNIFICANT IMPROVEMENT WITH
BENTRIO IN NASAL SYMPTOM

Source text for Eikon:  ID:nGNX93H79h 
Further company coverage:  CYTO.O 
 ((Reuters.Briefs@thomsonreuters.com;;))